ST14 and Sepsis: Whether antithrombin III increases mortality in matriptase hypomorphic mice following CBDL might be confounded by the known salutary effects of antithrombin III in sepsis, including the attenuation of both hepatocyte apoptosis (Huang et al. 2010) and endotoxemia-induced healing impairment in the colon (Diller et al. 2009), as well as preserved mucosal thickness and villus height following CBDL (Caglikulekci et al. 2004).